Objectives: Though predictive models have been constructed to determine the risk of recurrence in differentiated thyroid carcinoma, various aspects of these models are inadequate. Therefore, we aimed to construct, internally validate and implement on a mobile application a scoring system to determine this risk within 10 years. Conclusions: This study provides an instrument able to predict rapidly and very simply which patients with differentiated thyroid carcinoma have a greater risk of recurrence.
| INTRODUCTION
Although thyroid cancer is relatively uncommon, it is still the most frequent endocrine neoplasm in the body. 1 Differentiated thyroid cancer can relate to either papillary or follicular carcinoma. Of all the malignant thyroid tumours, papillary carcinoma is the most common, followed by follicular carcinoma. 2, 3 Differentiated thyroid carcinoma is associated with an important rate of recurrence. 4, 5 As in other countries, the incidence of differentiated thyroid carcinoma is also increasing in Spain. 1, 6 It is currently around 3 cases per 100 000 person-years in men and around 8 in women and accounts for 3.8% of all cancers. 6 The Valencian Community, located in the south east of Spain, has a population ranging from 3 722 362 in 1984 to 4 959 968 in 2016. 7 All the oncological services are free to access and free of charge for all residents in this Community.
Thyroid cancer is dealt with via a Committee of Endocrine and Thyroid Tumours, which decides the best therapeutic option after discussion of each individual case. 8 The treatment of differentiated thyroid carcinomas is surgery, generally total thyroidectomy, with postsurgical ablation of the thyroid remnants using radioactive iodine (doses of 100 mCi preferably given 3-5 weeks after thyroidectomy).
Treatment should then be given with L-thyroxine (usual dose: 2.4 μg/ kg/d). 9 This treatment underwent no great variation during the study period .
Analysis of hospital registries in the Valencian Community recorded over 33 years has enabled the construction, internal validation and implementation on a mobile application of a predictive model to determine the onset of recurrence in patients diagnosed with and treated for differentiated thyroid carcinoma. Unlike other studies (Table 1) , our model eliminates all the negative aspects of the various scoring systems proposed (absence of C-statistic and calibration, and an events-per-variable ratio less than 10) such that the results obtained have greater precision. In addition, our model is based on a simple points system that has been adapted for use as a mobile telephone application and which can be applied in daily clinical practice to immediately determine which patients are more likely to present recurrence due to differentiated thyroid carcinoma over a maximum period of 10 years. With this information, we can undertake a stricter follow-up of patients who have a high likelihood of recurrence. This is an important issue, as with the results of this study health care professionals treating patients with differentiated thyroid cancer will have available a new tool to help in decision-making. These professionals will be able to know, in real time, what the probability of recurrence is and thus be able to take the most suitable decision to benefit the affected patient.
| MATERIALS AND METHODS

| Ethical questions
This study was approved by the Ethics Committee of the Department of Health of Elda. Given that the study was undertaken using retrospective data, no informed consent was requested from the patients.
The Ethics Committee approved this procedure. All experiments were performed in accordance with relevant guidelines and regulations.
| Study population
The study comprised all patients diagnosed with and treated for dif- Treatment is available for everybody and at no cost to the patient. 
| Study design and participants
Keypoints
• Other authors have developed predictive models for recurrence in thyroid cancer.
• These models have negative aspects in its construction/ validation.
• We have estimated a model eliminating all these aspects.
• Our model is based on a scoring system.
• The scoring system has been adapted for use as a mobile app for Android.
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| Variables and measurements
The main outcome variable was the first appearance of recurrence of differentiated thyroid carcinoma during the follow-up (time-torecurrence), whether local in the thyroid surgery bed, regional in the cervical lymph nodes or distant. A patient was considered to have had a recurrence if this had been recorded as such in the databases mentioned above (Study design and participants).
The following secondary variables were also recorded at diagnosis in order to assess risk factors for recurrence: age, gender, known family history of differentiated thyroid carcinoma, main diagnosis (papillary or follicular), multifocality (solitary or multifocal), T, N, stage 14 and treatment (total thyroid surgery, cervical lymph node surgery and radioiodine). These variables were all obtained from the sources of information mentioned above.
| Sample size
The final cohort comprised 200 patients and 55 had an event (recurrence). Therefore with this sample size we could develop a predictive model with 5 predictors (events-per-variable = 55Ä5 = 11 > 10). 15 
| Statistical analysis
Absolute and relative frequencies were used to describe the qualitative variables, with means and standard deviations for the quantitative variables. A multivariate Cox regression model was constructed to calculate the adjusted hazard ratios (HR) and determine which variables were associated with recurrence. As we had few patients, we selected a maximum number of explanatory variables in the model. T, N and stage were considered linear quantitative variables, as they did not show a quadratic tendency (score test). As a heuristic rule, we considered there needed to be at least 10 observations of recurrence (events) for each explanatory variable. 15 To obtain the variables in the model we analysed all the possible combinations with a maximum of 5 variables (1585), calculating the value of the C-statistic in all of them. In other words, all the models with 5 (792 models), 4 (495 models), 3 (220 models), 2 (66 models) and 1 (12 models) predictors were estimated with their C-statistic. The combination with the highest value was then selected; that is, that set of variables that best predicted our outcome. The goodness-of-fit of the model was assessed by the score test. From the β coefficients of the multivariate model, a risk table was constructed based on the sum of the points to estimate the probability of recurrence using the Framingham Heart Study methodology. This method gives weights to the β coefficients and transforms each category of each of the factors into a score, in order to be able to calculate the probability of an event without the need for complex calculations. 16 Finally, so as to internally validate our scoring system, using 1000 bootstrap samples, we determined the C-statistic and flexible calibration curves using linear splines (5-and 10-year risk).
17
All the analyses were done with α = 5% and the associated confidence interval was calculated for each relevant parameter. All the analyses were done with IBM SPSS Statistics 19.0 (IBM, Armonk, NY, USA) and R 2.13.2.
| Mobile App
The model was implemented on a mobile telephone application local plus regional cervical lymph nodes plus distant metastasis, 5). This is equivalent to an incidence density of 294 recurrences per 10 000 person-years (95% CI: 222-383). 
| DISCUSSION
| Synopsis of new findings
In this study, we estimated and internally validated a scoring system to predict the 5-and 10-year risk of recurrence in patients with differentiated thyroid cancer. The methodology to validate the model took into account the discrimination and the calibration with the more powerful statistical techniques: C-statistic, bootstrapping and smooth calibration.
| Strengths of the study
The main strength of this study resides in the construction of a predictive model based on a scoring system that improves on previous models ( Table 1 ). The improvements centre around the choice of a suitable number of predictive variables and the calculation of the Cstatistic. This statistic is similar to the ROC curve, but the former takes into account censoring; therefore, it is very important to know its value in follow-up studies constructing predictive models. Additionally, recurrence probability was obtained for each score. Thus, the clinician can know which patients require a closer follow-up in order to reduce the incidence of recurrences in differentiated thyroid carcinoma.
As we used data recorded over a 33-year period with a retrospective design, we must accept a certain degree of information bias.
However, to minimise this bias, all the sources of information (both computerised and non computerised) were very strictly checked.
Furthermore, we have to take into account that the other studies which have developed predictive models also have a retrospective F I G U R E 1 Predictive model for total recurrence of differentiated thyroid carcinoma. The scoring system was constructed using the Framingham Heart Study methodology 16 F I G U R E 2 C-statistics distribution (bootstrapping) to validate the scoring system to predict total recurrence of differentiated thyroid carcinoma LÓPEZ-BRU ET AL.
| 29 design. [10] [11] [12] [13] In addition, although diagnostic criteria have changed slightly over the years, we used the seventh update of the AJCC, 14 revising in all cases the results of the pathological study, so that this does not vary throughout the study period. A similar situation arises with the follow-up, as the protocol for follow-up visits has hardly varied over the study period. Although the sample size may seem small (n = 200), our events-per-variable ratio was greater than 10.
This, therefore, shows that the sample size was sufficient for the aims of this study. Finally, we did not include genetic factors, like race, the thyroglobulin levels or surgical margins/adequacy of primary surgery, because this information was not recorded in our database (retrospective study) and all our patients were Caucasian. Even so, it should be noted that the predictions of the scoring system are precise without the inclusion of these variables.
| Comparisons with other studies
A study of the literature reveals various scoring systems, but they all differ from our study in the methodology used. They have defects in the construction (one study has an events-per-variable ratio less than 10) and goodness-of-fit (no internal validation was carried out in any of them), whereas in our study we considered these aspects, applying a suitable methodology for the selection of variables. Bearing in mind these methodological aspects, our model could prove a better tool to aid daily clinical practice with the prevention of recurrence of differentiated thyroid carcinoma, once they have been validated in other geographical areas (Table 1) .
Our model indicates that those patients with affected lymph nodes, a higher size of the tumour, multifocality and follicular cancer have a greater risk of recurrence. These parameters are mainly consistent with those in the current literature (Table 1) . [18] [19] [20] The factors introduced into our model were selected using statistical criteria (C-statistic), rather than introducing just the clinically relevant factors. Nevertheless, it should be recalled that the aim of a predictive model is to obtain the best possible prognosis, which is obtained from that combination of factors that minimises prediction error. If we had introduced factors relevant to recurrence that were not introduced into our model, for example, patient gender, our Cstatistic would have been lower and thus our model would not be useful to make the prediction, but just to study the associated factors. This was not the aim of the study, as we desired to construct a tool to predict recurrence in patients diagnosed with and treated surgically for differentiated thyroid carcinoma.
| Clinical applicability of the study
Once our model has been externally validated, the results of this study will provide daily clinical practice with a tool capable of predicting recurrence rapidly and simply (mobile app) with a high discriminatory power in patients diagnosed with and treated surgically for differentiated thyroid carcinoma. This mobile application will help to avoid possible calculation errors. Without it, we have to carry out time-consuming multiple calculations, whereas its use can immediately give us the exact calculated risk. Our system will enable us to stratify our patients and thus determine which patients are at a greater risk of recurrence. We can then try to establish the best adjuvant treatment option for these patients, with the more aggressive options reserved for the high-risk patients. Nonetheless, this idea needs further examination when the results of new studies are reported.
As with other scoring systems, we have to note that the results must be validated in different samples of patients, both the discriminatory capacity of our points system and the calibration. 17 Thus, if we obtain a satisfactory C-statistic and there are no differences between the expected and the observed risks, we shall be able to state that our model has been validated for use in general clinical practice. 17, 21 This validation process should be undertaken in other geographical areas and in different populations, as there might be differences with the study population used here.
F I G U R E 3
Smooth calibration plots (linear splines) of the scoring system to predict total recurrence of differentiated thyroid carcinoma. A, 5-y risk; B, 10-y risk
In conclusion, this study provides the clinical practice of treatment of differentiated thyroid carcinoma with a tool indicating rapidly and very simply (using a mobile phone application) which patients diagnosed with differentiated thyroid carcinoma have a greater risk of recurrence every 5 years (5 and 10 years). Nevertheless, we must be cautious as other prospective multicentre studies are needed to validate our results.
